Sanofi

🇫🇷France

Country: 🇫🇷France

Ownership: Public

Employees: 87.9K

Market Cap: $141.3B

Website: http://www.sanofi.com

Introduction: Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Clinical Trials

Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 2

Terminated

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: docetaxel
Drug: gemcitabine
Drug: bevacizumab

First Posted Date: 2006-09-20

Last Posted Date: 2010-01-26

Lead Sponsor: Sanofi

Target Recruit Count: 17

Registration Number: NCT00378573

Locations: 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States

HUPS: Hyalgan Use in Painful Shoulder

Phase 3

Completed

Conditions: Osteoarthritis of Shoulder

First Posted Date: 2006-09-18

Last Posted Date: 2011-01-11

Lead Sponsor: Sanofi

Target Recruit Count: 602

Registration Number: NCT00377624

Locations: 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States

An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses

Phase 4

Completed

Conditions: Actinic Keratoses

First Posted Date: 2006-09-18

Last Posted Date: 2008-04-10

Lead Sponsor: Sanofi

Target Recruit Count: 250

Registration Number: NCT00377273

Locations: 🇺🇸
Sanofi-Aventis, Bridgewater, New Jersey, United States

A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.

Phase 4

Completed

Conditions: Acne Vulgaris

First Posted Date: 2006-09-15

Last Posted Date: 2007-10-10

Lead Sponsor: Sanofi

Target Recruit Count: 60

Registration Number: NCT00377000

An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

Phase 2

Completed

Conditions: Anxiety Disorders

Interventions: Drug: SSR149415
Drug: Placebo
Drug: Paroxetine

First Posted Date: 2006-09-08

Last Posted Date: 2016-05-25

Lead Sponsor: Sanofi

Target Recruit Count: 325

Registration Number: NCT00374166

Locations: 🇺🇸
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States

Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene

Phase 3

Completed

Conditions: Hygiene

First Posted Date: 2006-09-04

Last Posted Date: 2008-05-16

Lead Sponsor: Sanofi

Target Recruit Count: 50

Registration Number: NCT00371852

Locations: 🇧🇷
Sanofi-aventis, São Paulo, Brazil

Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene

Phase 3

Completed

Conditions: Hygiene

First Posted Date: 2006-08-30

Last Posted Date: 2008-05-16

Lead Sponsor: Sanofi

Target Recruit Count: 30

Registration Number: NCT00370162

Locations: 🇧🇷
Sanofi-Aventis, São Paulo, Brazil

Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease

Phase 2

Completed

Conditions: Peripheral Arterial Disease

First Posted Date: 2006-08-25

Last Posted Date: 2008-11-18

Lead Sponsor: Sanofi

Target Recruit Count: 125

Registration Number: NCT00368797

Locations: 🇮🇹
Istituto Dermopatico dell'Immacolata, Roma, Italy
🇩🇪
Klinikum Karlsbad-Langensteinbach, Karlsbad, Germany
🇨🇭
Universitätsklinik, Bern, Switzerland

and more 3 locations